Specific CEA-producing colorectal carcinoma cell killing with recombinant adenoviral vector containing cytosine deaminase gene.

scientific article published on April 2002

Specific CEA-producing colorectal carcinoma cell killing with recombinant adenoviral vector containing cytosine deaminase gene. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3748/WJG.V8.I2.270
P932PMC publication ID4658365
P698PubMed publication ID11925606

P2093author name stringKun Yao
Qiang Ding
Li-Zong Shen
Wen-Xi Wu
Yi-Bing Hua
Xin-Yuan Liu
De-Hua Xu
Zhong-Cheng Zheng
P2860cites workAn integrin-targeted non-viral vector for pulmonary gene therapyQ45865697
Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery systemQ45867740
Enzyme/prodrug gene therapy for human colon cancer cells using adenovirus-mediated transfer of the Escherichia coli cytosine deaminase gene driven by a CAG promoter associated with 5-fluorocytosine administrationQ45868332
The Construction of an Adenovirus Vector Containing Cytosine Deaminase Gene and Its Application.Q54540137
Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancerQ73814757
[Tumor markers for colorectal cancer]Q74576753
Targeting adenovirusQ33837127
Modifying the host range properties of retroviral vectorsQ33876131
Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication.Q34005910
Gene therapy for colorectal cancer: therapeutic potentialQ34344921
Reduction of tumorigenicity of SMMC-7721 hepatoma cells by vascular endothelial growth factor antisense gene therapy.Q36397313
The prognostic value of preoperative serum levels of CEA, CA19-9 and CA72-4 in patients with colorectal cancerQ36397443
Inhibitory effect of IGF- II antisense RNA on malignant phenotype of hepatocellular carcinomaQ36491922
The therapeutic effects of recombinant adenovirus RA538 on human gastric carcinoma cells in vitro and in vivoQ36506433
Gene therapy for human colorectal carcinoma using human CEA promoter contro led bacterial ADP-ribosylating toxin genes human CEA: PEA & DTA gene transferQ36620118
Inhibitory effects of EGFR antisense oligodeox ynucleotide in human colorectal cancer cell line.Q40753765
Gene therapy of metastatic colon carcinoma: regression of multiple hepatic metastases by adenoviral expression of bacterial cytosine deaminaseQ40769500
Cytosine deaminase suicide gene therapy for peritoneal carcinomatosisQ40897254
Enhanced efficacy of transcriptionally targeted suicide gene/prodrug therapy for thyroid carcinoma with the Cre-loxP system.Q40943665
Adenovirus-mediated suicide gene transfer to small cell lung carcinoma using a tumor-specific promoter.Q43573063
Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovirQ43687893
In vivo suicide gene therapy model using a newly discovered prostate-specific membrane antigen promoter/enhancer: a potential alternative approach to androgen deprivation therapyQ43705366
Carcinoembryonic antigen-specific suicide gene therapy of cytosine deaminase/5-fluorocytosine enhanced by the cre/loxP system in the orthotopic gastric carcinoma model.Q43708562
Hepatic intra-arterial delivery of a retroviral vector expressing the cytosine deaminase gene, controlled by the CEA promoter and intraperitoneal treatment with 5-fluorocytosine suppresses growth of colorectal liver metastases.Q43710414
In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferaseQ43796867
Tumor-specific chemo-radio-gene therapy for colorectal cancer cells using adenovirus vector expressing the cytosine deaminase geneQ43809709
Mitochondrial amplification of death signals determines thymidine kinase/ganciclovir-triggered activation of apoptosis.Q44107370
Tumor-specific gene transfer via an adenoviral vector targeted to the pan-carcinoma antigen EpCAM.Q45861917
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectAdenoviridaeQ193447
colorectal carcinomaQ25493920
P304page(s)270-275
P577publication date2002-04-01
P1433published inWorld Journal of GastroenterologyQ15708885
P1476titleSpecific CEA-producing colorectal carcinoma cell killing with recombinant adenoviral vector containing cytosine deaminase gene
P478volume8

Reverse relations

cites work (P2860)
Q35085995Antitumor activity of mutant bacterial cytosine deaminase gene for colon cancer
Q40541147Construction and identification of recombinant vectors carrying herpes simplex virus thymidine kinase and cytokine genes expressed in gastric carcinoma cell line SGC7901.
Q40115005Construction of double suicide genes system controlled by MDR1 promoter with targeted expression in drug-resistant glioma cells
Q40061667Construction of humanized carcinoembryonic antigen specific single chain variable fragment and mitomycin conjugate
Q36534930Frontiers in Suicide Gene Therapy of Cancer
Q36178667Pre-operative radiochemotherapy of locally advanced rectal cancer
Q40498934Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer
Q39688817Targeted killing effects of double CD and TK suicide genes controlled by survivin promoter on gastric cancer cell
Q39476525The targeted gene (KDRP-CD/TK) therapy of breast cancer mediated by SonoVue and ultrasound irradiation in vitro
Q40651834Tumor necrosis factor-related apoptosis-inducing ligand gene on human colorectal cancer cell line HT29

Search more.